EMA Withdrawn: Nitisinone MDK (previously Nitisinone MendeliKABS) (nitisinone) — MendeliKABS Europe Ltd

View source ↗

Summary

EMA withdrawal of nitisinone MDK (nitisinone) from MendeliKABS Europe Ltd for tyrosinemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tyrosinemia

Drugs mentioned

• Nitisinone (Nitisinone)
• nitisinone MDK (nitisinone)

Snippet

Status: Withdrawn. Therapeutic area: Tyrosinemias. MAH: MendeliKABS Europe Ltd. Decision date: 15/07/2022